2024 Italy Respiratory Disease Market: Shares and Segment Forecasts-- Adenovirus, Coronavirus, Enterovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Rhinovirus, and Tuberculosis

August 2024 | | ID: 2B8F92BEE1E1EN
Venture Planning Group

Abstracts

This new report from LeadingMarketResearch.com provides analysis of the Italian respiratory disease testing market, including emerging technologies, instrumentation review, volume and sales segment forecasts by country, supplier shares, and strategic profiles of leading competitors.
About this Report
This report presents detailed analysis of the Respiratory Disease market in France.
Current scientific views on epidemiology and etiology are presented for:
Adenovirus
Coronavirus
Enterovirus
Influenza
Legionella
Mononucleosis
Mycoplasma
Pneumonia
RSV
Rhinovirus
Tuberculosis
The report provides test volume and sales forecasts by country and market segment.
The report is available by section, and can be customized to specific information needs and budget.
In addition to market share and sales forecasts, the report:
Examines market applications of molecular diagnostics, monoclonal antibodies, immunoassays, IT and other technologies.
Reviews features and operating characteristics of major analyzers used for respiratory disease testing;
Profiles key suppliers and potential market entrants developing innovative technologies and products
Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues.
Methodology
In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as LeadingMarketResearch's proprietary data files was conducted.

Contents

Worldwide Market and Technology Overview
A. Major Routine and Special Coagulation Tests
1. Introduction
2. Activated Partial Thromboplastin Time (APTT)
3. Alpha-2 Antiplasmin
4. Antithrombin III
5. Bleeding Time
6. D-Dimer
7. Ethanol Flocculation Test
8. Euglobulin Lysis
9. Factor Assays
a. Introduction
b. Factor II
c. Factor V/Factor V Leiden
d. Factor VII
e. Factor VIII
f. Factor IX
g. Factor IXa
h. Factor X (Stuart Factor)
i. Factor Xa
j. Factor XI
k. Factor XII
l. Factor XIII
10. Fibrin Degradation Products
11. Fibrinogen
12. Heparin
13. Hirudin
14. Hypercoagulability and Thrombosis
15. Lipoprotein a
16. Plasmin
17. Plasminogen
18. Plasminogen Activator Inhibitor (PAI)
19. Platelet Function Tests
20. Platelet Aggregation

21. Proteins C and S
22. Prothrombin Fragment 1.2
23. Prothrombin Time (PT)
24. Reptilase Time
25. Thrombin Time
26. Tissue-Type Plasminogen Activator (t-PA)
27. Von Willebrand's Factor
B. Instrumentation: Review of latest analyzers from Bio/Data, Cardiovascular
Diagnostics, Diagnostica Stago, Helena Laboratories, Instrumentation Laboratory,
NexusDx, Roche Diagnostics, Siemens Healthineers, Sysmex, and Teco
Diagnostics.
C. Major in Vitro Diagnostic Technologies And Their
Potential Applications
1. Chromogenic Substrates
2. Monoclonal and Polyclonal Antibodies
3. Immunoassays
a. Applications
b. Technological Principle
c. Enzyme Immunoassays (EIA)
- Overview
- ELISA
- EMIT
- Dot Immunobinding Assays
- Capillary Immunoassays
- Enzyme Amplification
- Electrochemical Immunoassay
d. Fluorescent Immunoassays
- Fluorescence Polarization
- Time-Resolved Pulse Fluorescence
- Fluorescence Lifetime
e. Latex Agglutination
f. Immunoprecipitation
4. Microcomputers
5. Automation
6. Robotics
7. DNA Probes
a. Overview
b. Amplification Methods